摘要
背景:电压依赖性阴离子通道(VDAC)蛋白代表线粒体外膜最重要的成孔蛋白,直接参与代谢和凋亡调控。文献已经强调了VDAC在许多神经退行性疾病典型的线粒体功能障碍中的关键作用。特别是主要的同种型VDAC1代表许多错误折叠蛋白的主要线粒体停靠位点,例如阿尔茨海默病中的β淀粉样蛋白和Tau蛋白,帕金森病中的α-突触核蛋白和肌萎缩侧索硬化中的几种SOD1突变体。错误折叠的蛋白质与VDAC1的相互作用对细胞生物能量学和细胞凋亡途径的改变都有很大的影响。因此,VDAC在神经退行性疾病中是有希望的治疗靶点。 目的:本综述总结了VDAC同种型,尤其是VDAC1在最常见的神经系统疾病中的作用,并详细分析了迄今为止可用的分子和多肽,能够在任何被考虑的病理状态下相互作用和调节VDAC1。 结论:这篇综述提供了对VDAC1最有前途的治疗策略的描述,用于治疗神经退行性疾病。
关键词: VDAC,线粒体功能障碍,神经退行性疾病,阿尔茨海默氏病,帕金森病,肌萎缩侧索硬化症。
Current Medicinal Chemistry
Title:Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules
Volume: 24 Issue: 40
关键词: VDAC,线粒体功能障碍,神经退行性疾病,阿尔茨海默氏病,帕金森病,肌萎缩侧索硬化症。
摘要: Background: The Voltage Dependent Anion Channel (VDAC) proteins represent the most important pore-forming proteins of the mitochondrial outer membrane, directly involved in metabolism and apoptosis regulation. Literature has highlighted a key role of VDACs in mitochondrial dysfunction typical of many neurodegenerative disorders. In particular, the principal isoform VDAC1 represents the main mitochondrial docking site of many misfolded proteins, such as amyloid β and Tau in Alzheimer's disease, α-synuclein in Parkinson's disease and several SOD1 mutants in Amyotrophic Lateral Sclerosis. The interaction of misfolded proteins with VDAC1 has a strong impact on both cellular bioenergetics and apoptosis' pathways alteration. Therefore, VDACs represent a promising therapeutic target in neurodegeneration.
Objective: This review summarizes the roles of VDAC isoforms, and particularly of VDAC1, in the most common neurological disorders and analyzes in detail molecules and peptides available so far, able to interact and modulate VDAC1 in any considered pathological condition.
Conclusion: This review offers a description of the most promising therapeutic strategies acting on VDAC1, for the treatment of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules, Current Medicinal Chemistry 2017; 24 (40) . https://dx.doi.org/10.2174/0929867324666170601073920
DOI https://dx.doi.org/10.2174/0929867324666170601073920 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry Biosynthesis of Flavin Cofactors in Man: Implications in Health and Disease
Current Pharmaceutical Design A Novel Physico-Chemical Property Based Model for Studying the Effects of Mutation on the Aggregation of Peptides
Protein & Peptide Letters Nanomedicine
Current Nanoscience Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease
Current Alzheimer Research Astroglial Connexins in Neurological and Neuropsychological Disorders and Radiation Exposure
Current Medicinal Chemistry A New Model for Academics Based Drug Discovery
Current Alzheimer Research The Pharmacokinetics and Toxicology of Aluminum in the Brain
Current Inorganic Chemistry (Discontinued) Eosinophils in Cancer: Favourable or Unfavourable?
Current Medicinal Chemistry Anti-Inflammatory Activity of Novel 12-N-methylcytisine Derivatives
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Kainate Receptors and Pain: From Dorsal Root Ganglion to the Anterior Cingulate Cortex
Current Pharmaceutical Design Exercise-Induced MicroRNA Regulation in the Mice Nervous System is Maintained After Activity Cessation
MicroRNA Podocyte Mitosis – A Catastrophe
Current Molecular Medicine Molecular Mechanisms Determining Opposed Functional States of Microglia
Current Neuropharmacology Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Competitive Gly/NMDA Receptor Antagonists
Current Topics in Medicinal Chemistry Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease
Current Pharmaceutical Design Meet the Editorial Board:
Current Topics in Medicinal Chemistry Molecular Structure of Ionotropic Glutamate Receptors
Current Medicinal Chemistry